SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Palestinian leader Abbas says elections only after Gaza war ends - 2NASA's Artemis II launch leaves Americans in awe: 'We're going back to the frickin' moon!'
- 3Step by step instructions to Get a good deal on Your Rooftop Substitution Venture
- 4Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
- 5Astronauts beam home Christmas wishes from International Space Station: 'I think we may be orbiting a little higher than Santa' (video)
- Nigeria warns its citizens in South Africa to be cautious after march turns violent
- Instructions to Improve Your Mental Exploration with Cutting edge Measurements
- After harsh winter, Ukrainians find joy in releasing bats rescued from war
- U.K. blocks Kanye West from entering Britain to headline now canceled festival: What led to the ban
- Explosions heard across Tehran after IDF announces wave of strikes on regime terror targets
- Swap The Amalfi Coast For This Low-Cost Ligurian Seaside Town
- Archaeologists uncover details about the Hjortspring boat's origins
- If someone's always late, is it time blindness, or are they just being rude?
- Carina Nebula shines with white-blue stars | Space photo of the day for Jan. 5, 2026
